Quay Pharma is expanding its services to support clinical trials with the establishment of a dedicated packing and distribution facility at its Deeside headquarters. The new MHRA-approved area allows Quay to provide both bulk delivery of product and to meet increasing demands for just-in-time deliveries to support randomized and blinded studies.
Quay offers the filling of primary packs including bottles, tubes, blister packs, sachets and oral dosing syringes, followed by secondary packing. The company offers multi-language labeling, blinding and randomization and, though its sister company, Chester Medical, can provide individually designed patient packs. Quay also supports cold chain management, including shipping and storage. The inclusion of tamper-evident seals and code break labels can be incorporated as part of the packing process.
“Quay has developed this service to assist a number of our clients for whom we have developed products, as they move through to Phase II and Phase III clinical trials,” said Quay Pharma chief executive Maireadh Pedersen. “This is an important enhancement to our client offering, enabling us to continue to support our customers throughout their development phase.”